US Broker Ratings

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 52-Week Highs and Lows for Future Growth

Investors with an eye on the healthcare sector might find Molina Healthcare Inc (NYSE: MOH) an intriguing opportunity. As a key player in the healthcare plans industry, Molina Healthcare provides..

Genmab A/S (GMAB) Stock Analysis: Evaluating a 50% Potential Upside in Biotechnology

Genmab A/S (GMAB), a leader in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline and robust analyst ratings. With a focus on developing antibody-based..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 27% Upside Potential in Healthcare’s OTC Market

Prestige Consumer Healthcare Inc. (PBH), a key player in the over-the-counter (OTC) healthcare products market, presents a compelling investment opportunity for those looking to capitalize on its potential 27.62% upside...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 20% Upside Potential

Roivant Sciences Ltd. (ROIV), a biopharmaceutical company based in London, is capturing investor attention in the biotechnology sector with its promising pipeline and a notable market capitalization of $19.82 billion...

ICON plc (ICLR) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to the clinical research market. With..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Examining the 51.55% Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotechnology sector, is making waves with its focus on developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in West Conshohocken, Pennsylvania,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Poised for 23.74% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a global player in the biotechnology sector, is capturing investor attention with a robust potential upside of 23.74% based on current analyst ratings. With a market..

Alkermes plc (ALKS) Investor Outlook: Evaluating a 55% Upside Potential with Solid Buy Ratings

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, operates in the competitive healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $4.69 billion,..

Legend Biotech Corporation (LEGN) Stock Analysis: A 233% Potential Upside Amidst Robust Revenue Growth

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology sector, focusing on innovative cell therapies aimed at treating various forms of cancer. The company’s flagship product candidate,..

UnitedHealth Group (UNH) Stock Analysis: A Look at 31% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable entity in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $250.15 billion, UnitedHealth is not..

ADMA Biologics Inc (ADMA): Investor Outlook on a Biotech Firm with 79% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling opportunity for investors with a keen interest in the healthcare sector, particularly within the biotechnology industry. Based in Ramsey, New Jersey, this..

Insmed Incorporated (INSM) Stock Analysis: A Promising Biotech with 56.62% Potential Upside

For investors in the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) represents a compelling opportunity, driven by its robust pipeline and significant potential upside of 56.62% based on current analyst targets...

Glaukos Corporation (GKOS) Stock Analysis: A 33% Upside Potential Amid Rapid Revenue Growth

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector, has caught the attention of investors with its cutting-edge medical devices aimed at treating a range of ophthalmic conditions...

Stevanato Group S.p.A. (STVN) Investor Outlook: Exploring a 74% Potential Upside

Stevanato Group S.p.A. (STVN), a key player in the healthcare sector, has been making waves in the medical instruments and supplies industry. Headquartered in Piombino Dese, Italy, the company is..

HCA Healthcare, Inc. (HCA) Stock Analysis: Potential Upside and Strong Buy Ratings Signal Growth Potential

Investors with a keen eye on the healthcare sector might find HCA Healthcare, Inc. (NYSE: HCA) an attractive proposition. With a market capitalization of $110.44 billion, HCA Healthcare stands as..

Nuvalent, Inc. (NUVL) Stock Analysis: Potential 51.88% Upside on Innovative Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is gaining attention from investors eager to capitalize on its promising pipeline of cancer therapies. With a market capitalization of $7.45 billion,..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 42% Potential Upside for Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, is catching the attention of investors with a compelling growth narrative and substantial potential upside. Operating in the..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 38% Potential Upside for Investors

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, specifically in diagnostics and research, is currently capturing investor attention with its promising financial metrics and substantial growth potential...

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 47.65% Upside Potential in the Biotech Sector

Investors eyeing opportunities in the healthcare sector may find TG Therapeutics, Inc. (NASDAQ: TGTX) an intriguing prospect. With a market capitalization of $4.81 billion, this biopharmaceutical company specializes in innovative..

The Ensign Group, Inc. (ENSG) Investor Outlook: Unpacking the 10.16% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, specifically in the medical care facilities industry, offers a compelling investment case with potential upside. Incorporated in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds